Table 2.
CXCR-4 | PKC-δ | CD133 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Negative (18) |
Positive (33) |
p Value | Negative (21) |
Positive (30) |
p Value | Negative (22) |
Positive (29) |
p Value | ||
No. of Patients | ||||||||||
Age | ||||||||||
≤60 | 26 | 12 | 14 | p < 0.14 | 10 | 16 | p < 0.77 | 8 | 18 | p < 0.09 |
>60 | 25 | 6 | 19 | 11 | 14 | 14 | 11 | |||
Gender | ||||||||||
Male | 29 | 11 | 18 | p < 0.77 | 15 | 14 | p < 0.09 | 14 | 15 | p < 0.56 |
Female | 22 | 7 | 15 | 6 | 16 | 8 | 14 | |||
Stage | ||||||||||
I–II | 24 | 9 | 15 | p < 0.78 | 14 | 10 | p < 0.02 * | 16 | 8 | p < 0.001 * |
III–IV | 27 | 9 | 18 | 7 | 20 | 6 | 21 | |||
Lymph node Metastasis | ||||||||||
Negative | 23 | 15 | 8 | p < 0.001 ** | 16 | 7 | p < 0.001 ** | 15 | 8 | p < 0.005 ** |
Positive | 28 | 3 | 25 | 5 | 23 | 7 | 21 | |||
Histological Grade | ||||||||||
Well Differentiated | 8 | 6 | 2 | p < 0.02 * | 6 | 2 | p < 0.10 | 7 | 1 | p < 0.008 ** |
Moderately Differentiated | 19 | 7 | 12 | 7 | 12 | 9 | 10 | |||
Poorly Differentiated | 24 | 5 | 19 | 8 | 16 | 6 | 18 | |||
Location of the Tumours | ||||||||||
Tongue | 15 | 8 | 7 | p < 0.42 | 7 | 8 | p < 0.54 | 6 | 9 | p < 0.56 |
Buccal | 9 | 3 | 6 | 5 | 4 | 4 | 5 | |||
Palate | 8 | 3 | 5 | 4 | 4 | 4 | 4 | |||
Gingiva | 10 | 2 | 8 | 3 | 7 | 6 | 4 | |||
Floor of Mouth | 9 | 2 | 7 | 2 | 7 | 2 | 7 |
Negative (0 and 1+ categories) and Positive (2+ and 3+ categories). * Statistically significant, ** Statistically highly significant.